Uveitis: Recognition, Referral & Co-management — A 2026 Update
Date: 22/04/2026 (AEST)
Venue: https://www.carinaleaguesclub.com.au/, QLD, 4152
Provider: LVF Ophthalmology Research Centre
Contact: Michelle Carley-Lep, [E] admin@lvfeyecentre.org.au, [P] 07 3398 9494
Activity Outline
This clinical presentation provides optometrists with an evidence-based update on uveitis diagnosis, classification and management. Content includes anatomical classification; red flags for same-day referral; topical and systemic pharmacological management; emerging drug-induced uveitis patterns (GLP-1 receptor agonists, checkpoint inhibitors, bisphosphonates); and a practical co-management framework.
Learning Objectives
- Classify uveitis anatomically and identify common aetiologies encountered in optometric practice
- Recognise clinical features requiring same-day, urgent, or routine ophthalmic referral
- Describe first-line pharmacological management of acute anterior uveitis including topical corticosteroids and cycloplegics
- Identify drug-induced uveitis patterns associated with GLP-1 receptor agonists and checkpoint inhibitors
- Apply a structured co-management framework for chronic and recurrent uveitis between optometrist and ophthalmologist
Max CPD hours awarded: 2.5
Session Information
| Name |
|---|
| Uveitis: Recognition, Referral & Co-management — A 2026 Update |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2.5 |